Your browser doesn't support javascript.
loading
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers.
Ismail, Magda M F; Shawer, Taghreed Z; Ibrahim, Rabab S; Abusaif, Mostafa S; Kamal, Mona M; Allam, Rasha M; Ammar, Yousry A.
Afiliação
  • Ismail MMF; Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University Cairo 11754 Egypt m.elalfy101@gmail.com magdaismail@azhar.edu.eg.
  • Shawer TZ; Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University Cairo 11754 Egypt m.elalfy101@gmail.com magdaismail@azhar.edu.eg.
  • Ibrahim RS; Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University Cairo 11754 Egypt m.elalfy101@gmail.com magdaismail@azhar.edu.eg.
  • Abusaif MS; Department of Chemistry, Faculty of Science, Al-Azhar University Cairo 11754 Egypt.
  • Kamal MM; Department of Pharmacology, Faculty of Pharmacy (Girls), 11754 Al-Azhar University Cairo Egypt.
  • Allam RM; Department of Pharmacology, Medical and Clinical Research Institute, National Research Centre 12622 Dokki Cairo Egypt.
  • Ammar YA; Department of Chemistry, Faculty of Science, Al-Azhar University Cairo 11754 Egypt.
RSC Adv ; 13(45): 31908-31924, 2023 Oct 26.
Article em En | MEDLINE | ID: mdl-37915441

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article